Financial statements Emmes Biopharma Poland
Balance sheet of Emmes Biopharma Poland
Company age:
Age:
14 y. 10 m.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of EMMES BIOPHARMA POLAND
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 551 241,10 | 867 221,20 | 2 148 485,56 | 3 350 629,61 |
| A. Fixed assets | 67 351,70 | 46 043,63 | 412 436,21 | 429 642,32 |
| B. Current assets | 483 889,40 | 821 177,57 | 1 736 049,35 | 2 920 987,29 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 551 241,10 | 867 221,20 | 2 148 485,56 | 3 350 629,61 |
| A. Equity | -343 049,78 | 549 184,05 | 1 606 401,33 | 2 880 281,70 |
| B. Liabilities and provisions for liabilities | 894 290,88 | 318 037,15 | 542 084,23 | 470 347,91 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 855 222,64 | 208 769,30 | 427 846,11 | 343 717,50 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.